This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMGO Imago BioSciences (IMGO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Imago BioSciences Stock (NASDAQ:IMGO) Get Imago BioSciences alerts:Sign Up Key Stats Today's Range$36.01▼$36.0150-Day Range$35.78▼$36.0152-Week Range$11.56▼$36.09VolumeN/AAverage Volume171,367 shsMarket Capitalization$1.22 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Read More Receive IMGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imago BioSciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMGO Stock News HeadlinesRA Capital-backed startup raises $100M; UCB sells China businessAugust 28, 2024 | finance.yahoo.comAvidity Biosciences Stock (NASDAQ:RNA), Analyst Ratings, Price Targets, PredictionsMay 4, 2024 | benzinga.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.September 18 at 2:00 AM | Brownstone Research (Ad)Imago Theatre aims to find out if time-traveling Neanderthals have answers to climate changeApril 13, 2024 | msn.comMerck: Better Times Ahead On Approvals And OutlookApril 2, 2024 | seekingalpha.comClarus Lifesciences III, L.P.'s Net WorthFebruary 23, 2024 | benzinga.comAnixa Biosciences Inc ANIXDecember 21, 2023 | morningstar.comMHarmony Biosciences shares are trading lower after the company reported Q4 financial results.February 23, 2023 | benzinga.comSee More Headlines IMGO Stock Analysis - Frequently Asked Questions How were Imago BioSciences' earnings last quarter? Imago BioSciences, Inc. (NASDAQ:IMGO) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.10. When did Imago BioSciences IPO? Imago BioSciences (IMGO) raised $105 million in an initial public offering (IPO) on Friday, July 16th 2021. The company issued 7,000,000 shares at $14.00-$16.00 per share. What other stocks do shareholders of Imago BioSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imago BioSciences investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Alphabet (GOOG). Company Calendar Last Earnings11/10/2021Today9/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMGO CIK1623715 Webwww.imagobio.com Phone415-529-5055FaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$42.31 million Net MarginsN/A Pretax MarginN/A Return on Equity-31.85% Return on Assets-30.07% Debt Debt-to-Equity RatioN/A Current Ratio13.15 Quick Ratio13.16 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.40 per share Price / Book5.63Miscellaneous Outstanding Shares33,822,000Free Float28,783,000Market Cap$1.22 billion OptionableNot Optionable Beta2.82 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:IMGO) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThe Return of The KingGold has just surpassed the euro to become the world’s #2 reserve asset — a milestone that signals a massive s...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imago BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imago BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMGO Stock Alerts